Cyclin D1 and prognosis in human breast cancer

International Journal of Cancer

Volumn 69, Issue 2, 1996, Pages 92-99

  Gillett, Cheryl ^a   Smith, Paul ^a   Gregory, Walter ^a   Richards, Michael ^a   Millis, Rosemary ^a   Peters, Gordon ^b   Barnes, Diana ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLINE;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA; CYCLIN D1; CYCLINS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; ONCOGENE PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; SURVIVAL ANALYSIS; TAMOXIFEN;

EID: 0029893319     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.0.CO;2-Q     Document Type: Article

References (24)

1. BARTKOVA, J., LUKAS, J., MüLLER, H., LÜTZHøFT, D., STRAUSS, M. and BARTEK, J., Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57, 353-361 (1994).
2. BARTKOVA, J., LUKAS, J., STRAUSS, M. and BARTEK, J., Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10, 775-778 (1995).
3. BATES, S., PARRY, D., BONETTA, L., VOUSDEN, K., DICKSON, C. and PETERS, G., Absence of cyclin D/cdk complexes in cells lacking functional retinoblastorna protein. Oncogene. 9. 1633-1640 (1994).
4. BATES, S. and PETERS, G., Cyclin D1 as a cellular proto-oncogene. Sem. Cancer Biol., 6, 73-82 (1994).
5. BUCKLEY, M.F., SWEENEY, K J.E., HAMILTON, J.A., SINI, R.L., MANNING, D.L., NICHOLSON, R I., DE FAZIO, A., WATTS, C.K.W., MUSGROVE, E.A. and SUTHERLAND, R.L., Expression and amplification of cyclin genes in human breast cancer. Oncogens, 8, 2127-2133 (1993).
6. CAMPLEJOHN, R.S., Flow cytometry in clinical pathology. In: C.S. Herrington and J.O.D. McGee (eds.), Diagnostic molecular pathology: a practical approach, pp. 238-259. IRL Press, Oxford (1992).
7. 1 cyclins. Curr. Opin. Cell Biol.. 6, 842-846 (1994).
8. FANTL, V., SMITH, R., BROOKES, S., DICKSON, C. and PETERS, G., Chromosome 11q13 abnormalities in human breast cancer. Cancer Surveys, 18, 77-94 (1993).
9. GILLETT, C., FANTL, V., FISHER, C, BARTEK, J., DICKSON, C., BARNES, D. and PETERS. G., Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817 (1994).
10. GOLDING, H., PINDER, S., CANNON, P., PEARSON, D., NICHOLSON, R., SNEAD, R., BELL, J., ELSTON, C.W., ROBERTSON, J.F., BLAMEY, R.W. and ELLIS, LO., A new method for the assessment of oestrogen receptor status on routine formalin fixed tissue samples. Human Pathol., 26, 291-294 (1995).
11. JIANG, W., ZHANG, Y.-J., KAHN, S.M., HOLLSTEIN, M.C., SANTELLA, R.M., LU, S.-H., HARRIS, C.C., MONTESANO, R. and WEINSTEIN, I.B., Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 90, 9026-9030 (1993).
12. KALBFLEISCH, J.D. and PRENTICE, R.L., The statistical analysis of failure time data, J. Wiley, New York (1980).
13. KHATIB, Z.A., MATSUSHIME, H., VALENTINE, M., SHAPIRO, D.N., SHERR, C.J. and LOOK, A.T., Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53, 5535-5541 (1993).
14. KING, R.J.B., REDGRAVE, S., HAYWARD, J.L., MILLIS, R.R. and RUBENS, R.D., The measurement of receptors for oestradiol and progesterone in human breast tumours. In: R.J.B. King (ed.), Steroid receptor assays in breast tumors: methodological and clinical aspects, pp. 55-73, Alpha-Omega, Cardiff, UK (1979).
15. LAMMIE, G.A., FANTL, V., SMITH, R., SCHUURING, E., BROOKES, S., MICHALIDES, R., DICKSON, C., ARNOLD, A. and PETERS, G., D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene, 6, 439-444 (1991).
16. MOTOKURA, T. and ARNOLD, A., Cyclins and oncogenesis. Biochim. biophys. Acta. 1155, 63-78 (1993).
17. MÜLLER, H., LUKAS, J., SCHNEIDER, A., WARTHOE, P., BARTER, J., EILERS, M. and STRAUSS, M., Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. nat. Acad. Sci. (Wash.), 91, 2945-2949 (1994).
18. 1NK4 MTS1 suppressor gene product. EMBO J., 14, 503-511 (1995).
19. PETERS, G., FANTL, V., SMITH, R., BROOKES, S. and DICKSON, C., Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res. Treat., 33, 125-135 (1995).
20. PETO, R., PIKE. M.C., ARMITAGE, P., BRESLOW, M.E., Cox, D.R., HOWARD, S.V., MANTEL, N., MCPHERSON, K., PETO, J. and SMITH, P.G., Design and analysis of clinical trials requiring prolonged observation of each patient: II analysis and examples. Bru. J. Cancer, 35, 1-39 (1977).
21. SCHAUER, I.E., SIRIWARDANA, S., LANGAN, T.A. and SCLAFANI, R.A., Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc. nat. Acad. Sci. (Wash.), 91, 7827-7831 (1994).
22. SHEAFF, R.J. and ROBERTS, J.M., Lessons in p16 from phylum Falconium. Curr. BioL., 5, 28-31 (1995).
23. 1 progression. Oncogene, 9, 2663-2674 (1994).
24. VAN DE VIJVER, M.J., Molecular genetic changes in human breast cancer. Adv. Cancer Res., 61, 25-56 (1993).